Reata Pharmaceuticals Inc
RETA · Chemicals & Drugs · NASDAQ · in our data May 26, 2016 to September 25, 2023 (7.3 years)
The first trading day in our data for Reata Pharmaceuticals Inc is May 26, 2016 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on February 4, 2020, the market valued it at $6.9 billion. It left the market when it was bought or merged, last trading at $172.36, -30.4% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2016. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2023: Chemicals & Drugs
- Seagen Inc peaked at $43.2 billion
- Intercept Pharma Inc peaked at $9.0 billion
- Amyris Inc peaked at $6.0 billion
- Iveric Bio Inc peaked at $5.5 billion
- Sorrento Therapeutics Inc peaked at $4.6 billion
- Sio Gene Therapies Inc peaked at $3.0 billion
